142 天前 - … They are involved in the pathophysiology of various neurodegenerative and
neuropsychiatric ailments such as Parkinson's disease, Alzheimer's disease, major depressive …

144 天前 - … efficacy endpoints in clinical trials of pharmacological or emerging nonpharmacological
treatments. In the era of disease-modifying therapy, imaging biomarkers are expected …

151 天前 - … drug-delivery techniques like polymer-based nano-carriermediated administering
drugs have emerged … successful strategy against the Parkinson's disease [229230231. The …

152 天前 - … diseases (NDDS), CLASP proteins, responsible for regulating microtubule dynamics
in neurons, have emerged … , such as Alzheimer's, Parkinson's, and Huntington's diseases. …

159 天前 - … Since the advent of iPSCs, 42,43 stem cell technology, particularly iPSCs, has
emerged as a powerful tool for investigating disease. Through patient-specific iPSCs derived …

163 天前 - … Currently, there are no disease-modifying agents for the treatment of PD. Zebrafish
(Danio rerio) have emerged as an effective tool for new drug discovery and screening in the …

165 天前 - … and distressing Parkinson’s disease (PD), an impending need emerged for
deciphering … SH-SY5Y-based in vitro neuronal models have emerged as a new possibility for the …

171 天前 - … (E)-3-chloro-N′-(1-phenylethylidene) benzohydrazide remarkably emerged as a
lead … and reduce the progression of Parkinson's disease. Previously reported MAO inhibitors …

171 天前 - … like Alzheimer's disease (AD) and Parkinson's disease (PD… As a consequence,
luteolin has emerged as an option for … use of luteolin as a drug of choice for the treatment as well …

173 天前 - … of single and multitarget nanoparticles for disease detection and drug delivery to the
brain, … Functionalized nanoparticles have emerged as promising tools for the diagnosis and …